Shortage reports
Actual shortage:
58 (4%)
Anticipated shortage:
2 (0%)
Avoided shortage:
37 (3%)
Resolved:
1273 (93%)
1370
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
10 (16%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RISEDRONATE | 35MG | TABLET | Resolved | 2024-07-08 | 2024-08-05 | 232420 |
| PMS-RISEDRONATE | 150MG | TABLET | Resolved | 2019-11-15 | 2020-03-10 | 98850 |
| PMS-RISEDRONATE | 35MG | TABLET | Resolved | 2018-12-11 | 2019-05-09 | 69240 |
| PMS-RISEDRONATE | 35MG | TABLET | Resolved | 2017-05-11 | 2017-11-17 | 10109 |
| PMS-RISEDRONATE | 35MG | TABLET | Resolved | 2019-01-16 | 2019-05-09 | 72635 |
| PMS-RISEDRONATE | 150MG | TABLET | Resolved | 2017-07-25 | 2017-11-17 | 17088 |
| PMS-RISEDRONATE | 35MG | TABLET | Avoided shortage | 2017-06-07 | 2017-07-25 | 12226 |
| PMS-RISPERIDONE | 1.0MG | TABLET | Resolved | 2018-02-12 | 2018-06-29 | 39549 |
| PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2018-01-26 | 2018-04-19 | 37328 |
| PMS-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-10-27 | 2017-12-15 | 27354 |
| PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2017-05-02 | 2017-06-09 | 8633 |
| PMS-RISPERIDONE | 3.0MG | TABLET | Resolved | 2018-02-12 | 2018-06-29 | 39552 |
| PMS-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-09-08 | 2017-11-09 | 21715 |
| PMS-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-09-08 | 2017-11-17 | 21712 |
| PMS-RISPERIDONE | 1MG | SOLUTION | Resolved | 2023-10-30 | 2024-03-16 | 208577 |
| PMS-RISPERIDONE | 2.0MG | TABLET | Resolved | 2018-05-04 | 2018-07-13 | 48558 |
| PMS-RISPERIDONE | 1.0MG | TABLET | Resolved | 2018-01-26 | 2018-05-05 | 37325 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6337 |
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6340 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-04-10 | 2020-06-09 | 6343 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2018-01-26 | 2018-01-26 | 37263 |